Prostate Cancer Vaccine - Northwest Biotherapeutics: CaPVax, DC1/HRPC, DCVax - Prostate

Author：  

Publisher： Adis International

ISSN： 1173-8804

Source： BioDrugs, Vol.16, Iss.3, 2002-01, pp. : 226-227

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prostate cancer

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 33-32

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Prostate cancer

By  

Journal of Pain Management, Vol. , Iss. , 2017-01 ,pp. : 82-81

Nova Science Publishers, Inc.

Access to resources Recommend Favorite

Prostate Cancer: Advances in Immunotherapy

By Hurwitz A.A.  

BioDrugs, Vol. 17, Iss. 2, 2003-01 ,pp. : 131-138

Adis International

Access to resources Recommend Favorite

Prostate Cancer Vaccines: Current Status and Future Potential

By Doehn Christian   Böhmer Torsten   Kausch Ingo   Sommerauer Martin   Jocham Dieter  

BioDrugs, Vol. 22, Iss. 2, 2008-01 ,pp. : 71-84

Adis International

Access to resources Recommend Favorite

Pulmonary amyloidosis mimicking prostate cancer metastasis

By  

Clinical Case Reports, Vol. 3, Iss. 7, 2015-07 ,pp. : 626-628

John Wiley & Sons Inc

Access to resources Recommend Favorite